Enzyme, substrate, and myeloma in Gaucher disease.
Hughes
Derralynn A
DA
Lysosomal Storage Disorders Unit, Department of Academic Haematology, Royal Free Hospital and University College Medical School, London, United Kingdom. d.hughes@medsch.ucl.ac.uk
D000818:Animals; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D005776:Gaucher Disease / Q000145:classification / Q000150:complications / Q000208:ethnology / Q000235:genetics* / Q000276:immunology; D018740:Genetic Heterogeneity; D020022:Genetic Predisposition to Disease; D005838:Genotype; D005962:Glucosylceramidase / Q000172:deficiency / Q000235:genetics* / Q000502:physiology; D006801:Humans; D006942:Hypergammaglobulinemia / Q000209:etiology; D015994:Incidence; D007585:Jews / Q000235:genetics; D051379:Mice; D009101:Multiple Myeloma / Q000453:epidemiology / Q000235:genetics*; D009369:Neoplasms / Q000453:epidemiology / Q000235:genetics; D009928:Organ Specificity; D010641:Phenotype; D017354:Point Mutation; D012306:Risk
D016207:Cytokines; D005962:Glucosylceramidase